http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Tumor Imaging by Monoclonal Antibodies Labeled with Radioactive Metal Ions
( K. Endo ),( H. Sakahara ),( T. Nakashima ),( M. Koizumi ),( M. Kunimastsu ),( H. Ohta ),( T. Furukawa ),( Y. Ohmomo ),( Y. Arano ),( A. Yokoyama ),( K. Okada ),( O. Yoshida ),( S. Hosoi ),( T’ Nakam 대한핵의학회 1984 핵의학 분자영상 Vol.18 No.2
Beam Spot Imaging System Using a Fluorescent Screen for Carbon-ion Radiotherapy
K. Mizushima,E. Takeshita,T. Furukawa,Y. Hara,T. Shirai,K. Katagiri,K. Noda 한국물리학회 2013 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.63 No.7
A two-dimensional (2D) beam imaging system with a fluorescent intensifying screen and highspeedcharge-coupled device (CCD) camera was developed to observe the fluctuations of the beamposition and size. This system can perform imaging of the beam spot and the calculation of bothits position and size from the obtained image with a cycle-time of 20 ms. For quality assurance ofscanned carbon-ion therapy, we measured the stability of the unscanned-beam position and size byusing this system at the isocenter in a treatment room. We confirmed that the fluctuation rangesof its position and size were less than the tolerance for scanning irradiation.
Role of Rho-kinase in regulation of insulin action and glucose homeostasis
Furukawa, Noboru,Ongusaha, Pat,Jahng, Wan Jin,Araki, Kazushi,Choi, Cheol Soo,Kim, Hyo-Jeong,Lee, Yong Hee,Kaibuchi, Kozo,Kahn, Barbara B.,Masuzaki, Hiroaki,Kim, Jason K.,Lee, Sam W.,Kim, Young-Bum Elsevier 2005 Cell metabolism Vol.2 No.2
<P><B>Summary</B></P><P>Accumulating evidence indicates an important role for serine phosphorylation of IRS-1 in the regulation of insulin action. Recent studies suggest that Rho-kinase (ROK) is a mediator of insulin signaling, via interaction with IRS-1. Here we show that insulin stimulation of glucose transport is impaired when ROK is chemically or biologically inhibited in cultured adipocytes and myotubes and in isolated soleus muscle ex vivo. Inactivation of ROK also reduces insulin-stimulated IRS-1 tyrosine phosphorylation and PI3K activity. Moreover, inhibition of ROK activity in mice causes insulin resistance by reducing insulin-stimulated glucose uptake in skeletal muscle in vivo. Mass spectrometry analysis identifies IRS-1 Ser632/635 as substrates of ROK in vitro, and mutation of these sites inhibits insulin signaling. These results strongly suggest that ROK regulates insulin-stimulated glucose transport in vitro and in vivo. Thus, ROK is an important regulator of insulin signaling and glucose metabolism.</P>
Nguyen, Phuong T. K.,Nguyen, Huong T. D.,Pham, Hung Q.,Kim, Jaheon,Cordova, Kyle E.,Furukawa, Hiroyasu American Chemical Society 2015 Inorganic Chemistry Vol.54 No.20
<P>Four crystalline, porous metal–organic frameworks (MOFs), based on a new hexatopic linker, 1′,2′,3′,4′,5′,6′-hexakis(4-carboxyphenyl)benzene (H<SUB>6</SUB>CPB), were synthesized and fully characterized. Interestingly, two members of this series exhibited new topologies, namely, <B>htp</B> and <B>hhp</B>, which were previously unseen in MOF chemistry. Gas adsorption measurements revealed that all members exhibited high CO<SUB>2</SUB> selectivity over N<SUB>2</SUB> and CH<SUB>4</SUB>. Accordingly, breakthrough measurements were performed on a representative example, in which the effective separation of CO<SUB>2</SUB> from binary mixtures containing either N<SUB>2</SUB> or CH<SUB>4</SUB> was demonstrated without any loss in performance over three consecutive cycles.</P><P>The synthesis of metal−organic frameworks (MOFs) using multicarboxylate linkers has afforded new materials with unique structural features and interesting intrinsic properties. Accordingly, we prepared a new hexacarboxylate linker, and through one-pot solvothermal reactions, four new crystalline MOFs were constructed. All members exhibited selective CO<SUB>2</SUB>-capture properties, and a representative example was demonstrated to effectively separate CO<SUB>2</SUB> from binary gas mixtures containing N<SUB>2</SUB> or CH<SUB>4</SUB>.</P><P><B>Graphic Abstract</B> <IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/inocaj/2015/inocaj.2015.54.issue-20/acs.inorgchem.5b01900/production/images/medium/ic-2015-01900p_0001.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/ic5b01900'>ACS Electronic Supporting Info</A></P>
Y. Hara,T. Furukawa,K. Mizushima,S. Sato,T. Shirai,K. Noda,E. Takeshita 한국물리학회 2013 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.63 No.7
A two-dimensional dosimetry system was developed for the quality assurance (QA) of therapeuticscanned ion beams at Heavy Ion Medical Accelerator in Chiba (HIMAC). This system consists of afluorescent screen and a charge-coupled device (CCD) camera. To evaluate the performance of thissystem, we carried out a few experiments concerning QA procedures. A verification of this systemwas also carried out by comparing the film dosimetry and the ionization chamber array. Also, weverified several types of corrections for errors, e.g., background and vignetting, that distort themeasurement results. As a result, we confirmed that this system could be used for QA proceduresof the therapeutic scanned ion beams.